| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.00B | 17.55B | 12.66B | 9.78B | 10.80B | 10.53B |
| Gross Profit | 4.14B | 5.43B | 3.48B | 3.40B | 4.56B | 3.80B |
| EBITDA | 1.01B | 1.53B | 638.46M | 1.05B | 2.55B | 2.13B |
| Net Income | -2.68B | 213.67M | -1.04B | 104.05M | 1.16B | 807.30M |
Balance Sheet | ||||||
| Total Assets | 10.89B | 11.88B | 13.53B | 14.17B | 12.25B | 9.68B |
| Cash, Cash Equivalents and Short-Term Investments | 3.93B | 6.38B | 3.93B | 5.94B | 6.04B | 4.74B |
| Total Debt | 4.29B | 3.12B | 4.73B | 6.47B | 3.84B | 3.01B |
| Total Liabilities | 7.95B | 6.83B | 8.81B | 8.51B | 6.62B | 5.11B |
| Stockholders Equity | 2.94B | 5.04B | 4.72B | 5.66B | 5.63B | 4.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.18B | 626.38M | -475.64M | 2.64B | 1.53B |
| Operating Cash Flow | 0.00 | 2.20B | 634.08M | -473.24M | 2.67B | 1.60B |
| Investing Cash Flow | 0.00 | 1.87B | -899.38M | -2.05B | -2.02B | -1.77B |
| Financing Cash Flow | 0.00 | -1.62B | -1.74B | 2.41B | 658.83M | -387.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥42.03B | 7.24 | ― | 4.06% | 9.32% | 243.34% | |
63 Neutral | ¥8.97B | 9.99 | ― | ― | -21.20% | 141.82% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | ¥11.41B | 52.88 | ― | ― | 38.66% | ― | |
54 Neutral | ¥13.04B | 8.44 | ― | ― | 2.70% | -30.63% | |
51 Neutral | ¥10.97B | -24.06 | ― | ― | 2.67% | -203.45% | |
42 Neutral | ¥18.47B | -4.17 | ― | ― | -17.15% | -70.83% |